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ABSTRACT 
Aurora Kinase C, a vital serine-threonine protein Kinase, is an important member of the Aurora Kinase protein family which plays an important 
role in mitosis is a part of Chromosomal Passenger Complex (CPC).  Aurora Kinase C overexpression is found to be linked with several cancer cell 
lines which demonstrate its oncogenic involvement and activity. Aurora C overexpression in certain cancer types makes it an important target to 
be considered for cancer therapeutics. The present research work focuses on Aurora Kinase C as an important target for computational studies. 
The protein model of  Aurora Kinase C, as a protein target on docking with 1500 natural compounds (phytochemicals) reveals the binding of the 
natural ligand 3-beta,23,28-trihydroxy-12-oleanene 23-caffeate belonging to the terpenoid class with highest docking score. This best-bound 
ligand with the protein Aurora Kinase C was chosen for further understanding their protein-ligand interactions at the molecular level using the 
molecular dynamics simulation approach. Stability of the protein-ligand complex and its conformation helps in disclosing the potentiality of the 
best-bound ligand to be further chosen as an important small molecule inhibitor that would help to play a lead role in the further drug discovery 
process. 
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1. INTRODUCTION 
According to WHO Cancer fact sheets, cancer is the second 
leading cause of deaths throughout the globe which have 
been responsible for the total of 8.8 million deaths 
worldwide in the year 2015 (ref link: 
http://www.who.int/en/news-room/fact-
sheets/detail/cancer ). The  burden of cancer have been 
predicted to be increasing globally, up-to 15 million by the 
year 2020, wherein the developing countries would be at the 
higher risk relating to incidences of cancer morbidity and 
mortality 1. 
Aurora Kinases, the serine-threonine protein kinases that 
have been evolutionarily conserved are the novel kinases 
which plays a vital role in normal cell mitosis events as well 
as tumorigenesis in cancerous cells 2. During mitosis, the 
Aurora kinase family of proteins plays an indispensable role 
at varied stages for cellular development. Their aberrant 
expression caused by genetic instability could be a cause of 
cancer due to its over-expression 3 . The three Aurora 
Kinases have been found to be mapped on the intrinsically 
unstable regions of chromosomes giving a better explanation 
about their aberrant expression in various cancer types such 
as leukemia4,5. Aurora C   expression is found to be normally 
expressed in the testis, whereas its aberrant expression is 
also found in certain cancer cell lines6.   
Of all the three kinases, Aurora Kinase C has been lesser 
reviewed and is found to be overexpressed in cancer types 
such as Breast cancer, Colorectal cancer, cervical cancer, 
prostate cancer, liver cancer as well as Gliomas 3,4,6. It had 
also been demonstrated that the mechanism of  CpG 
methylation helps in further regulation of the expression of 
Aurora Kinase C gene in cancerous cells 7. Aurora Kinase C is 
considered as a proto-oncogene as it aids for amplification in 
centrosome and multinucleation activity while its 
overexpression. Its overexpression in NIH-3T3 cells also 
promoted tumor formation in nude mice8 . 
Overexpression of Aurora Kinase C and its prognostic role 
had been found to be demonstrated in the invasive breast 
cancer and prostate cancer cells 9. Aurora C at the DNA level 
has been found to exhibit Gene amplification and thus 
overexpression in the breast cancer cell lines 10. Increased 
Aurora Kinase C activity has been found to be involved in 
tumorigenesis by promoting the cellular proliferation 
activities10. Published Literature suggests the 
overexpression of Aurora Kinase C in diverse cell lines such 
as hematological, breast and prostate cancer cell lines 5,11,12.  
Overexpression of genes related to Aurora C and Survivin 
has been found to play an important role in the development 
of colorectal cancer 12,13 . 
Aurora C overexpression which results in phenotypical 
expression of polyploid cells with the abnormal centrosome 
numbers has been found to be provoked in the absence of 
p5314. It had also been found that the overexpression of 
Aurora C caused an interference with the spindle checkpoint 
activation mediated by Aurora B10. This further implies that 
the Aurora kinase C tends to decrease the activity of Aurora 
kinase B. Moreover the overexpression of Aurora Kinase C 
protein implicated an increase in the tumorigenicity of the 
cancerous cells11.   
Aurora Kinase C protein, which thus serves as a promiscuous 
target for cancer therapy have been further explored 
through computational approaches such as protein modeling 
and have been chosen as a Protein target receptor. The 
library of 1500 naturally occurring compounds with proven 
anti-cancer activity from the NPACT database have been 
docked with the Aurora Kinase C protein structure which 
helped in exploring the binding efficacy of best ligand from 
the large pool of natural ligands, that could further help in 
the pathophysiological conditions such as cancer arising 
from its overexpression. 
2. MATERIALS AND METHODS 
Aurora C Protein Modeling and protein preparation 
The Aurora Kinase C protein structure model had been 
predicted through its amino acid sequence available in 
Uniprot (http://www.uniprot.org/) with uniprot ID: 
Q9UQB915. Using automated I-Tasser (The iterative 
threading assembly refinement) Server 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER), the 3d 
atomic models of the Protein structure have been built 
through the iterative threading assembly simulations 
technique16,17,18. 
A meta threading program LOMETS which consists of 
multiple threading algorithms, the given amino acid query 
sequence identification of the structural templates is done. 
Full-length topology model is constructed by the 
reassembling process of the continuously aligned protein 
fragment structures from the templates19. The unaligned 
regions in the structures are built by the ab initio procedure 
of folding which is based on the replica-exchange Monte 
Carlo simulations19,20. Trajectories are then constructed by 
the clustering approach based program, SPICKER for two 
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rounds in order to produce a refined structural model21,22. 
Another round of structural reassembly was performed for 
the refinement of structural models. Conformations having 
lower free-energy further refined by full atomic simulation 
process by the help of ModRefiner and FG-MD22,23.  
Preparation of protein prior to docking was done by deleting 
water molecules and cleaning the protein in YASARA 
Structure followed by Energy minimization using the 
YAMBER force field24. 
Natural ligands dataset and ligand preparation 
NPACT (Naturally occurring plant-based Anti-Cancer 
compound activity Target Database) is an important 
database related to the plant derived natural anticancer 
compounds 25. It consists of around 1500 natural ligands 
which were further compiled into data-sets and used for the 
docking purpose. These ligands were cleaned and the 
hydrogens were added to the ligands for further use using 
Marvin Sketch tool.   
Molecular Docking 
YASARA Structure (version 17.8.15) have been utilized for 
the protein-ligand docking purpose26. It is based on the 
Autodock Vina algorithm and it utilizes the following formula 
for calculating the docking score.  
ΔG= ΔG(vdw)+ΔG(HBond)+ΔG(elec)+ΔG(tor)+ΔG(desolv). 
Wherein, ΔG(vdw) is the component energy terms related to 
van der wals bond, ΔG(HBond) is the component energy term 
related to Hydrogen bonds, ΔG(elec) is the component energy 
terms related to electrostatics, ΔG(tor) is the component 
energy term related to the ligand’s torsional free energy and 
ΔG(desolv)is the component energy term related to the 
desolvation for the empirical calculation of the 
docking/binding energy for a protein-ligand complex. The 
Higher docking score represents the better protein-ligand 
binding whereas, the negative score represents no binding 
between the Protein and the ligand. The protein-ligand 
interactions were further visualized in 3D and 2Dusing the 
Accelrys Discovery Studio Visualizer. 
Molecular Dynamics Simulation 
The protein-ligand complex with highest binding energy 
have been selected for the Molecular Dynamics simulations 
and was simulated for the 30ns production period time with 
the constant number of atoms at the constant pressure and 
temperature using the AMBER14 force field 27,28. The 
molecular dynamics simulation had been performed at 1 bar 
pressure, 298 K temperature, along with 0.9% NaCl at 
physiological pH of 7.4 at solvent density 0.997, time steps of 
1 fs with periodic boundaries and all atoms in mobile state 
29,30. The default water model TIP3P (Three-site Transferable 
Intermolecular Potential) had been chosen for the Molecular 
dynamics simulation 31. Estimation of the binding affinity in 
terms of time vs energy  along with time vs RMSD were 
further calculated to decipher the stability of the protein-
ligand complex.   
3. RESULTS AND DISCUSSION 
Aurora C- Protein modelling 
The predicted protein model with the C- Score (confidence 
score) of -0.93 had been selected for further computational 
studies wherein, the C- score with higher value depicts the 
model with high confidence. 
 
Figure 1(A): Protein model of Aurora C protein kinase obtained by threading. (B.) Ramachandran plot for the Aurora C 
protein kinase obtained after energy minimization 
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After protein structure minimization the number of residues 
in the favoured region, allowed region and outlier regions 
are 92.2 %, 7.2 % and 0.7 % respectively. The Ramachandran 
plot for the protein model has been shown in the figure 1. 
The predicted normalised B-factor values for the protein are 
shown in the figure 2. The B-factor value shows an indication 
of the extent of inherent thermal mobility of the amino acid 
residues/ atoms in the protein structure. Normalised B-
factor values are inferred from the template proteins known 
while threading process. 
 
  
Figure 2: Normalised B- factor values for the protein Aurora Kinase C 
Molecular Docking 
The molecular docking studies reveals the binding affinity of 
the natural ligands towards the Aurora C protein model. 
Various types of interactions such as hydrogen bond 
interactions, pi-sigma bond, alkyl bond and pi- alkyl bond 
were observed in the protein- ligand interaction complex. 
Key contacting receptor residues were also noted. The top 
three protein-ligand complexes with the respective binding 
energies, dissociation constants and the number of hydrogen 
bonds are noted in the table-1. Better binding of the ligand 
towards the protein chain is indicated by the higher positive 
binding energy, whereas the negative binding energies 
indicate no binding. 
Table 1: Top 3 Molecular Docking Results of phytochemicals with Aurora Kinase C. 
Sr. No. Ligand Name 
Binding energy 
[kcal/mol] 
No. Of H-
bonds 
Contacting receptor residues 
1 
3-beta,23,28-
trihydroxy-12-oleanene 
23-caffeate. 
9.171 3 
LEU 49, LYS 51, GLY 52, LYS 53, PHE 54, VAL 57, ALA 70, 
LYS 72, LEU 104, LEU  120, GLU 127, LYS 130, ASP 166, 
LYS  168, GLU 170, ASN 171, LEU173, ALA  183 ,ASP 184, 
TRP 187, GLY 201, THR 202, LEU 203. 
2 
3-beta-trans-(3,4-
dihydroxycinnamoyl-
oxy)olean-12-en-28-oic 
acid 
9.133 2 
GLU 136, LYS 137, LEU 138, ASP 139, GLU  140, TYR 230, 
LEU 233, VAL 234, GLY  235, TYR 236, GLU 240, ARG 250, 
ARG  257, PHE 258, PRO 259, SER 261, MET  262, PRO 
263, TRP 292. 
3 Gitoxin 9.035 6 
GLU 136, LYS 137, LEU 138, ASP 139, GLU 140, TYR 230, 
LEU 233, VAL 234, GLY 235, TYR 236, PRO 237, PRO 238, 
GLU 240, ARG 250, ARG 257, PRO 259, SER 261, MET 262, 
PRO 263, TRP 292. 
 
 
Figure: 3 2D and 3D Protein ligand complex representation of Aurora C protein with ligand 3-beta_23_28-trihydroxy-
12-oleanene 23-caffeate. 
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Figure 4: 2D Protein ligand complex representation of Aurora C protein with ligand 3-beta-trans-(3_4-
dihydroxycinnamoyl-oxy) olean-12-en-28-oic acid 
 
Figure 5: 2D and 3D Protein ligand complex representation of Aurora C protein with ligand Gitoxin 
Molecular Dynamics Simulations  
The best bound protein-ligand complex of Aurora C with the 
terpenoid 3-beta_23_28-trihydroxy-12-oleanene 23-caffeate 
had been subjected to Molecular dynamics simulations using 
AMBER 14 force Field in NPT ensemble wherein, the number 
of atoms, pressure and temperature are constant. The Time 
(ns) vs Energy (kJ/mol) plot demonstrated the fluctuations 
of the simulated complexes wherein, the energy values 
ranged from -3698145.074 kJ/mol to -2827450 kJ/mol. The 
average energy value had been observed to be -2834566.119 
kJ/mol. The major peaks with energy values in kJ/mol were 
observed to be -2827768.52, -2827450.13, -2827547.37, -
2830373.04 and -2830576.36 at 1.7 ns, 8.2 ns, 12.2 ns, 12.9 
ns and 23.6 ns respectively. 
 
 
Figure 6: Time (ps) vs Energy (kJ/mol) of the best bound protein-ligand complex 
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The time vs RMSD plot aided further in revealing the stability 
of the protein- ligand complex. The minimum and the 
maximum RMSD observed were 0.459 Å and 13.576 Å 
respectively. Average RMSD of 8.230 Å had also been 
observed during the production time period of 30ns. 
 
Figure 7: Time (ps) vs RMSD (Å) of the best bound protein-ligand complex. 
 
Molecular dynamics simulations results significantly 
explains about the stability of the protein-ligand complex. 
The time vs RMSD and time vs Energy fluctuations result 
demonstrates the binding affinity of the protein-ligand 
complex along with the conformational changes associated 
with protein-ligand complex for the production period of 
30ns.
 
 
Figure 8: Changes in Protein-ligand complex observed after every 2.5 ns of the molecular dynamics simulation (30 ns). 
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At every 2500 ps step interval the trajectory was exported 
for analysis of the dynamic interaction profile of the the 
Aurora C Protein with the top bound ligand 3-beta,23,28-
trihydroxy-12-oleanene 23-caffeate (figure 9). 
Initially the Hydrogen bond interactions between the ligand 
3-beta,23,28-trihydroxy-12-oleanene 23-caffeate and the 
Aurora C protein were observed with the residues Asp 184, 
Lys 53, Glu 127, Gly 201, Leu 203 and Lys 51 at the distance 
of 1.63 Å, 1.97 Å, 2.89 Å, 2.16 Å, 2.40 Å, 1.70Å  respectively. 
Furthermore, the ligand the alkyl bonds bonds with the 
residues Trp187, Ala 183, Val 57,and Leu 173 were observed 
at the distances of 5.42 Å, 5.13 Å, 4.64 Å and 4.57 Å 
respectively. It had been observed that the Hydrogen bond 
interaction of the ligand with the Lys 53 residue was found 
to be conserved for the 20 ns time interval. Hydrogen bond 
interaction of the ligand with the residue Asp184 and Lys 51 
along with the alkyl bond interaction with the residue Als 
183 and Lys 53 were also been found to be conserved for the 
30 ns time interval. 
4. CONCLUSION 
Aurora Kinase C is overexpressed in many cancer types and 
can be considered as a target for anti-cancer therapy. 
Screening of varied phytochemicals with the protein Aurora 
C Kinase have been performed using the Molecular docking 
approach wherein the ligand 3-beta,23,28-trihydroxy-12-
oleanene 23-caffeate, a terpenoid, 3-beta-trans-(3,4-
dihydroxycinnamoyl-oxy)olean-12-en-28-oic acid , a  steroid 
and Gitoxin, a steroidial glycoside has been observed to be 
the interacting with the protein Aurora Kinase C with the 
binding energies of 9.171 kcal/mol, 9.133, kcal/mol and 
9.035 kcal/mol, respectively. The protein-ligand complex of 
Aurora Kinase C with the topmost ligand  3-beta,23,28-
trihydroxy-12-oleanene 23-caffeate were further subjected 
to molecular dynamics simulations for 30 ns time interval. 
The time (ps) vs RMSD (Å) and Time (ps) vs Energy (kJ/mol) 
plots were plotted for the same and the time (ps) vs energy 
(kJ/mol) plot showed nearly stable energy conformation 
throughout the production period of 30 ns. The hydrogen 
bond interaction of the ligand with the protein residue Asp 
184 and Lys 51 was found to be conserved for the 30 ns time 
interval.  The molecular hits identified in the study can be 
further tested in vitro before claiming its inhibitory potential.  
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